天津中医药大学第二附属医院品牌怎么样 申请店铺

我要投票 天津中医药大学第二附属医院在中医院行业中的票数:595 更新时间:2026-01-09
天津中医药大学第二附属医院是哪个国家的品牌?「天津中医药大学第二附属医院」是 天津中医药大学第二附属医院 旗下著名品牌。该品牌发源于天津,由创始人孙增涛经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力天津中医药大学第二附属医院品牌出海!将品牌入驻外推网,定制天津中医药大学第二附属医院品牌推广信息,可以显著提高天津中医药大学第二附属医院产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

天津中医药大学第二附属医院怎么样

天津中医药大学第二附属医院始建于20世纪60年代初期,经过五十年的积淀,已成为以中医、中西医结合治疗为特色的综合性三级甲等中医医院,是全国百姓放心示范医院。

医院以“国粹医粹仁和仁术”为院训,秉承“承担社会责任,一切服务病人,打造一流学科,培养卓越人才”的办院宗旨,服务范围覆盖本市河北区、河东区、东丽区、北辰区及滨海新区,服务范围从本市辐射到华北地区,服务人口近200万人,并吸引许多国外患者前来就医。

医院坚持以学科建设为核心,以技术进步为动力,以规范管理为保障的工作思路,建设以中医为主,中西医结合,医疗带动,医教研综合发展的现代化综合医院。目前,医院学科专科体系日渐成熟,为国家中医药继教基地;中医妇科学、中医肺病学、中医疮疡病学、中医心病学、临床中药学、中医“治未病”学为国家中管局重点学科;是国家药监局药品临床试验机构;拥有天津市首家获得17025认可的药代动力学实验室;是天津市首家、全国第三家中医院伦理审查委员会通过认证的医院;是天津中医药大学疑难病研究中心。拥有磁共振成像系统、快速成像螺旋扫描CT机等先进设备。

The Second Affiliated Hospital of Tianjin University of traditional Chinese medicine was founded in the early 1960s. After 50 years of accumulation, it has become a comprehensive three-level first-class hospital of traditional Chinese medicine with the characteristics of integrated treatment of traditional Chinese medicine and Western medicine. It is a demonstration Hospital of National People's confidence. The hospital takes "the quintessence of Chinese medicine, the quintessence of benevolence and benevolence", adheres to the tenet of "undertaking social responsibility, serving patients, building first-class disciplines, and cultivating outstanding talents". Its service scope covers Hebei District, Hedong District, Dongli District, Beichen District and Binhai New Area of the city. Its service scope covers nearly 2 million people from the city to North China, and attracts many foreign patients Come to see a doctor. The hospital adheres to the working idea of taking discipline construction as the core, technological progress as the driving force, standardized management as the guarantee, and builds a modern comprehensive hospital with traditional Chinese medicine as the main body, integrated traditional Chinese and Western medicine, driven by medical treatment, and integrated development of medical teaching and research. At present, the discipline and specialty system of the hospital is becoming more and more mature, which is the national base of traditional Chinese medicine. Gynecology of traditional Chinese medicine, pulmonary disease of traditional Chinese medicine, sore and sore disease of traditional Chinese medicine, cardiology of traditional Chinese medicine, clinical Chinese medicine, and "prevention of disease" of traditional Chinese medicine are the key disciplines of the State Administration of central management. It is the clinical trial institution of drugs of the State Administration of medicine. It has the first pharmacokinetic laboratory recognized by 17025 in Tianjin. It is It is the first hospital in Tianjin and the third hospital in China that has passed the certification of ethics review committee, and it is the research center of difficult diseases of Tianjin University of traditional Chinese medicine. It has advanced equipment such as MRI system, fast imaging spiral CT machine, etc.

本文链接: https://brand.waitui.com/54b7d6b83.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

2小时前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

2小时前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

2小时前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

2小时前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

2小时前

本页详细列出关于天津中医药大学第二附属医院的品牌信息,含品牌所属公司介绍,天津中医药大学第二附属医院所处行业的品牌地位及优势。
咨询